Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Portugal

 

Orpea won’t stop nursing home M&A drive

Orpea's smaller PE-backed French rivals who are spilling out across Europe say they are not worried by the Orpea scandal. Colissee has just acquired in Portugal for the first time. HBI talks to the C-level at the French operator to learn more.

Lusiadas Saude for sale

HBI hears Lusiadas Saude, Portugal’s third-largest hospital group by revenue, is for sale. Meanwhile, imaging and labs may be affected by the surprise re-election of the leftist Socialist government. HBI speaks with a healthcare consultant in Portugal to find out more. 

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.

Diaverum rolls out algorithm to predict thrombosis

Vascular access thrombosis is an expensive and painful complication for dialysis patients, with an incident rate of 0.11-0.5 episodes per patient per year. Global dialysis provider Diaverum has started to roll out an algorithm that can predict 75% of cases missed by current practices, enabling earlier interventions.

HBI Interview: Carlos Nueno, President, International, Teladoc 

How fast is the world outside America adopting telehealth and digital care in all its forms? Who better to ask than Carlos Nueno, president International for Teladoc Health, which ties with Ping An from China for the title of the world’s largest telehealth operator. So, what new business models are being rolled out and when? And how are countries adopting the new technology?

Portugal’s PPP experiment all but dead

Politics has finally ended Portugal's public-private partnership (PPP) hospital experiment. Just one operator, Ribera Salud, bid for the renewal of the final contract rendering the competition process invalid. By the end of the year, all four of the once-privately managed hospitals will likely return to the public sphere.

How Affidea is driving 10% MRI scan growth

European imaging provider Affidea sees 10% volume growth on MRI scans where it has deployed a programme to track how and when machines are used with proprietary software. Senior VP regional COO Zisis Sotiriou talks to HBI about how it has optimised clinical protocols, identified efficiency savings and gained an extra €2m revenue a year.

The new group building a hospital for millennials

Portugal has a new private hospital company which is building specialised acute care framed around the consumer behaviour of millennials. Why does the sector need a new player? Because the traditional operators have more difficulty in deploying good digital transformation, the project's CEO tells HBI.

Market conditions right for Unilabs to sell

HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit. 

EMEA’s Top 100 largest groups by revenue revealed

HBI’s inaugural HBI Health Care Services Top 100 lists the largest 100 companies by EMEA health care services revenue. In total revenue their revenue came to over €105bn - and we've uncovered some surprising winners and losers. 

Find Us